Search Results - "Isenberg D"

The immunological personality of close relatives of SLE patients.

Authors: Salaman, M. R. Isenberg, D. A.

Source: Lupus. Dec2017, Vol. 26 Issue 14, p1513-1516. 4p.

Use of the luminescent bacterial system for the rapid assessment of aquatic toxicity.

Authors: Bulich, A. A. Isenberg, D. L.

Source: ISA Transactions; 1981, Vol. 20 Issue 1, p29-33, 5p

A study of the influence of ethnicity on serology and clinical features in lupus.

Authors: Morais, S. A. Isenberg, D. A.

Source: Lupus. Jan2017, Vol. 26 Issue 1, p17-26. 10p. 4 Charts.

The overlap of systemic lupus erythematosus and sickle cell disease: report of two cases and a review of the literature.

Authors: Cherner, M. Isenberg, D.

Source: Lupus. Jun2010, Vol. 19 Issue 7, p875-883. 9p. 1 Chart.

Thirty years, five hundred patients: some lessons learned from running a lupus clinic.

Authors: Isenberg, D.¹ d.isenberg@ucl.ac.uk

Source: Lupus. May2010, Vol. 19 Issue 6, p667-674. 8p. 4 Charts.

New therapies in systemic lupus erythematosus - trials, troubles and tribulations.... working towards a solution.

Authors: Isenberg, D. Gordon, C. Merrill, J. et al.

Source: Lupus. Nov2008, Vol. 17 Issue 11, p967-970. 4p. 1 Chart.

Treating patients with lupus with B-cell depletion.

Authors: Isenberg, D. A.¹ d.isenberg@ucl.ac.uk

Source: Lupus. 2008, Vol. 17 Issue 5, p400-404. 5p. 1 Diagram.

Immunizing patients with systemic lupus erythematosus: a review of effectiveness and safety.

Authors: O'Neill, S. G. Isenberg, D. A.

Source: Lupus. 2006, Vol. 15 Issue 11, p778-783. 6p. 1 Chart.

New therapies for rheumatoid arthritis.

Authors: Goldblatt, F. Isenberg, D. A.

Source: Clinical & Experimental Immunology. May2005, Vol. 140 Issue 2, p195-204. 10p.

New therapies for systemic lupus erythematosus.

Authors: Goldblatt, F. Isenberg, D. A.

Source: Clinical & Experimental Immunology. May2005, Vol. 140 Issue 2, p205-212. 8p.

Anti-B cell therapy (Rituximab) in the treatment of autoimmune diseases.

Authors: Chambers, S. A. Isenberg, D.

Source: Lupus. 2005, Vol. 14 Issue 3, p210-214. 5p.

Novel therapies in lupus nephritis.

Authors: Tahir, H. Isenberg, D. A.

Source: Lupus. 2005, Vol. 14 Issue 1, p77-82. 6p.

Anti-dsDNA antibodies: still a useful criterion for patients with systemic lupus erythematosus?

Authors: Isenberg, D.¹ d.isenberg@ucl.ac.uk

Source: Lupus. 2004, Vol. 13 Issue 11, p881-885. 5p.

Clinical laboratory assays for measuring anti-dsDNA antibodies. Where are we now?

Authors: Isenberg, D Smeenk, R

Source: Lupus. 2002, Vol. 11 Issue 12, p797-800. 4p.

Biological treatments for systemic lupus erythematosus.

Authors: Isenberg, D. Leckie, M. J.

Source: Scandinavian Journal of Rheumatology. Aug2002, Vol. 31 Issue 4, p187-191. 5p.

Lupus in the family--analysis of a cohort followed from 1978 to 1999.

Authors: Giles, I. Isenberg, D.

Source: Lupus. Jan2001, Vol. 10 Issue 1, p38-44. 7p.

From BILAG to BLIPS—disease activity assessment in lupus past, present and future.

Authors: Isenberg, D. Gordon, C.

Source: Lupus. 2000, Vol. 9 Issue 9, p651-654. 4p.

Factors associated with mood and mood disorders in SLE.

Authors: Shortall, E. Isenberg, D. Newman, S.P.

Source: Lupus. Aug1995, Vol. 4 Issue 4, p272-279. 8p.

Is There a Case for Minsky's Financial Fragility Hypothesis in the 1920s?

Authors: Isenberg, D. L.¹

Source: Journal of Economic Issues. Dec88, Vol. 22 Issue 4, p1045. 25p. 7 Charts.

BILAG, SLEDAI, SIS, ECLAM,WAM, SLAM …. Thank you MAM.

Authors: Isenberg, D. A.¹ d.isenberg@ucl.ac.uk

Source: Lupus. 2007, Vol. 16 Issue 11, p849-851. 3p.